03/03
Headlines

VVUS

Gilead Sciences GILD NASDAQ:GILD

Unusual Volume At Healthcare: VIVUS (NASDAQ:VVUS), Span-America Medical Systems (NASDAQ:SPAN), Cyberonics (NASDAQ:CYBX), RXi Pharmaceuticals Corp (NASDAQ:RXII)

Jayne Crisman02 mins

VIVUS (NASDAQ:VVUS) last posted its quarterly earnings results on Monday, February 24th. The company reported ($0.17) earnings per share for the quarter, beating the analysts’ consensus estimate of ($0.40) by $0.23. VIVUS, Inc. (NASDAQ:VVUS)stock performance was 3.34% in last session and finished the day at $ 5.26. Traded volume was 2,821,422 shares in the last…

Read More

Hot Biotech Movers: VIVUS (NASDAQ:VVUS), MannKind Corporation (NASDAQ:MNKD), Arena Pharmaceuticals (NASDAQ:ARNA), Ariad Pharmaceuticals (NASDAQ:ARIA)

Chris Lewis02 mins

VIVUS Inc (NASDAQ:VVUS) will be announcing its Q114 earnings results on Monday, May 5th. Analysts expect the company to announce earnings of ($0.37) per share and revenue of $11.40 million for the quarter. VIVUS, Inc. (NASDAQ:VVUS) stock performance was -2.12% in last session and finished the day at $5.09. Traded volume was 1.34million shares in…

Read More

Healthcare Stocks Touched New Lows: VIVUS (NASDAQ:VVUS), Akebia Therapeutics Inc (NASDAQ:AKBA), Versartis Inc (NASDAQ:VSAR), BioLife Solutions (NASDAQ:BLFS)

Kristen Barton02 mins

VIVUS Inc. (NASDAQ:VVUS) lower following news late Tuesday night that three directors — J. Martin Carroll, Mark B. Logan and Robert N. Wilson — will not stand for re-election to the company’s Board. This will be the sixth-straight session for the stock to close lower. VIVUS, Inc. (NASDAQ:VVUS) stock performance was 0.20% in last session…

Read More